Check out this episode of Diabetes Dialogue where hosts Natalie Bellini, DNP, BC-ADM, CDCES and Diana Isaacs, PharmD, BCACP, BC-ADM, CDCES break down topline results from ATTAIN-1
Conclusion: Our data show that exposure to systemic glucocorticoids during hospitalisation increases the risk of new-onset diabetes 2.6 times compared to non-exposure
Key Research Applications This peptide combo is widely studied in the following areas: Appetite regulation & satiety signaling Obesity and weight-loss models Glucose tolerance and insulin sensitivity Type 2 diabetes and metabolic syndrome Liver fat reduction and cardiovascular outcomes (emerging preclinical interest) Product Specifications Peptides : Cagrilintide (5 mg) + Semaglutide (5 mg) Form : Lyophilized powder Vials per pack : 10 Purity : 98%, confirmed via HPLC and Mass Spectrometry Grade : Research-use only Storage : Store in a cool, dry place
Most palpitations experienced during a calorie deficit are benign and resolve once eating patterns are normalised or nutritional deficiencies are corrected
Pauls Hospital and Vancouver General Hospital
:format(webp))
